JP2011510019A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011510019A5 JP2011510019A5 JP2010543285A JP2010543285A JP2011510019A5 JP 2011510019 A5 JP2011510019 A5 JP 2011510019A5 JP 2010543285 A JP2010543285 A JP 2010543285A JP 2010543285 A JP2010543285 A JP 2010543285A JP 2011510019 A5 JP2011510019 A5 JP 2011510019A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- composition
- amino acid
- isolated peptide
- tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2213108P | 2008-01-18 | 2008-01-18 | |
| US61/022,131 | 2008-01-18 | ||
| PCT/US2009/031305 WO2009126349A2 (en) | 2008-01-18 | 2009-01-16 | Methods and compositions related to internalizing rgd peptides |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013231861A Division JP2014028862A (ja) | 2008-01-18 | 2013-11-08 | Ｒｇｄ１ペプチドの内部移行に関係する方法および組成物 |
| JP2016053595A Division JP2016121182A (ja) | 2008-01-18 | 2016-03-17 | Ｒｇｄ１ペプチドの内部移行に関係する方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011510019A JP2011510019A (ja) | 2011-03-31 |
| JP2011510019A5 true JP2011510019A5 (enExample) | 2013-01-31 |
| JP5985152B2 JP5985152B2 (ja) | 2016-09-06 |
Family
ID=41117566
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010543285A Active JP5985152B2 (ja) | 2008-01-18 | 2009-01-16 | Ｒｇｄ１ペプチドの内部移行に関係する方法および組成物 |
| JP2013231861A Pending JP2014028862A (ja) | 2008-01-18 | 2013-11-08 | Ｒｇｄ１ペプチドの内部移行に関係する方法および組成物 |
| JP2016053595A Pending JP2016121182A (ja) | 2008-01-18 | 2016-03-17 | Ｒｇｄ１ペプチドの内部移行に関係する方法および組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013231861A Pending JP2014028862A (ja) | 2008-01-18 | 2013-11-08 | Ｒｇｄ１ペプチドの内部移行に関係する方法および組成物 |
| JP2016053595A Pending JP2016121182A (ja) | 2008-01-18 | 2016-03-17 | Ｒｇｄ１ペプチドの内部移行に関係する方法および組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US8367621B2 (enExample) |
| EP (1) | EP2242764B1 (enExample) |
| JP (3) | JP5985152B2 (enExample) |
| CN (1) | CN101951938B (enExample) |
| AU (1) | AU2009234338B2 (enExample) |
| BR (1) | BRPI0906739A2 (enExample) |
| CA (1) | CA2710554A1 (enExample) |
| WO (1) | WO2009126349A2 (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2250278B1 (en) * | 2008-02-21 | 2023-04-05 | Burnham Institute for Medical Research | Methods and compositions related to peptides and proteins with c-terminal elements |
| US8263133B2 (en) * | 2009-02-18 | 2012-09-11 | The Regents Of The University Of California | Multivalent clustering targeting strategy for drug carriers |
| BRPI1015424B1 (pt) * | 2009-06-22 | 2022-01-18 | Burnham Institute For Medical Research | Composição compreendendo um elemento cendr e uma co-composição e composição para uso no reforço da internalização, penetração, ou ambas, de uma co-composição |
| WO2011127405A1 (en) | 2010-04-08 | 2011-10-13 | Sanford-Burnham Medical Research Institute | Methods and compositions for enhanced delivery of compounds |
| WO2012040105A2 (en) * | 2010-09-21 | 2012-03-29 | Kansas State University Research Foundation | Renilla/gaussia transfected cells as a light source for in-situ photodynamic therapy of cancer |
| WO2012118778A1 (en) | 2011-02-28 | 2012-09-07 | Sanford-Burnham Medical Research Institute | Truncated car peptides and methods and compositions using truncated car peptides |
| US10179801B2 (en) | 2011-08-26 | 2019-01-15 | Sanford-Burnham Medical Research Institute | Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides |
| US9969791B2 (en) * | 2012-06-07 | 2018-05-15 | National Cheng Kung University | Modified fibronectin fragments or variants and uses thereof |
| USD730496S1 (en) | 2012-11-06 | 2015-05-26 | Michael Schulze | Plumbing pipe |
| US20140186265A1 (en) * | 2012-11-27 | 2014-07-03 | Colorado State University Research Foundation | Multifunctional bacteriophage for delivery of therapeutic agents and imaging reagents |
| USD729910S1 (en) | 2013-05-15 | 2015-05-19 | MPS Technologies, LLC | Plumbing pipe |
| JP6391676B2 (ja) * | 2013-05-23 | 2018-09-19 | アジュ ユニバーシティー インダストリー−アカデミック コーオペレイション ファウンデーションＡｊｏｕ Ｕｎｉｖｅｒｓｉｔｙ Ｉｎｄｕｓｔｒｙ−Ａｃａｄｅｍｉｃ Ｃｏｏｐｅｒａｔｉｏｎ Ｆｏｕｎｄａｔｉｏｎ | ニューロピリンに特異的な腫瘍浸透性ペプチド及びこのペプチドが融合された融合タンパク質 |
| CN104774246B (zh) * | 2014-03-21 | 2018-05-04 | 中山大学附属肿瘤医院 | Nrp-1特异性肿瘤靶向多肽及其应用 |
| US10669311B2 (en) | 2015-04-23 | 2020-06-02 | Sanford Burnham Prebys Medical Discovery Institute | Targeted delivery system and methods of use therefor |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11084852B2 (en) | 2015-06-15 | 2021-08-10 | Oklahoma Medical Research Foundation | Ubiquitin interacting motif peptides as therapeutics |
| EP3124052A1 (de) * | 2015-07-30 | 2017-02-01 | Albrecht Piiper | Verfahren zur diagnose von karzinomen mittels irgd und magnetresonanztomographie (mrt) |
| RU2599462C1 (ru) * | 2015-09-22 | 2016-10-10 | Общество с ограниченной ответственностью "БИОТЕХНОЛОГИЯ" (ООО "БИОТЕХНОЛОГИЯ") | Способ полисигнальной активации апоптоза клеток злокачественных солидных опухолей |
| CN107375288B (zh) | 2016-05-16 | 2019-08-23 | 博瑞生物医药（苏州）股份有限公司 | 多臂的聚合靶向抗癌偶联物 |
| KR101926918B1 (ko) * | 2016-08-30 | 2018-12-07 | 한양대학교 산학협력단 | 항암 활성을 갖는 펩티드, 이를 유효성분으로 함유하는 암 예방 및 치료용 약학 조성물 및 건강기능식품 조성물 |
| EP3354270A4 (en) * | 2016-10-21 | 2019-04-24 | Obshestvo S Ogranichennoi Otvetstvennost'yu "Biotehnologiya" | METHOD FOR ACTIVATION OF APOPTOSIS OF CELLS WITH MULTIPLE SIGNALING OF SOLID MALIGNANT TUMORS |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| WO2018204392A1 (en) * | 2017-05-02 | 2018-11-08 | Stanford Burnham Prebys Medical Discovery Institute | Tumor associated monocyte/macrophage binding peptide and methods of use thereof |
| CN108484733B (zh) * | 2018-03-01 | 2021-06-25 | 国家纳米科学中心 | 双亲性靶向穿膜肽及其自组装的纳米探针、载药纳米颗粒 |
| CN108676097B (zh) * | 2018-05-24 | 2020-01-14 | 北京肽和生物科技有限公司 | 一种靶向肿瘤细胞的嵌合肽或嵌合蛋白及其应用 |
| WO2020030954A1 (en) | 2018-08-09 | 2020-02-13 | Integrative Medicine Clinic, Sia | Theranostics-like protein sanps conjugated to integrin and pmsa targeting peptides and therapy of prostate cancer |
| US20230050515A1 (en) * | 2021-05-04 | 2023-02-16 | Cend Therapeutics, Inc. | iRGD-ANALOGS AND RELATED THERAPEUTIC METHODS |
| US12351653B1 (en) | 2019-03-08 | 2025-07-08 | Lisata Therapeutics, Inc. | Pharmaceutical compositions comprising novel cyclic peptides |
| US11471497B1 (en) | 2019-03-13 | 2022-10-18 | David Gordon Bermudes | Copper chelation therapeutics |
| WO2021207742A1 (en) | 2020-04-10 | 2021-10-14 | Mi2 Holdings LLC | Nanoparticles for use in photodynamic therapies and methods of making, evaluating and using the same |
| CN111690071A (zh) * | 2020-07-01 | 2020-09-22 | 中国药科大学 | 一种具有靶向穿膜性的抗肿瘤多肽 |
| JP2023551771A (ja) * | 2020-12-01 | 2023-12-13 | ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク | 免疫調節剤を用いて免疫療法に対するがんの感受性を高める方法 |
| US20220378711A1 (en) * | 2021-05-11 | 2022-12-01 | United States Government As Represented By The Department Of Veterans Affairs | PH-Responsive Nanoparticles for Treating Cancer |
| CN115466311A (zh) * | 2021-06-10 | 2022-12-13 | 首都医科大学 | 抗粘附迁移和侵袭的18β-甘草次酸-RGDK,其合成,抗癌转移活性和应用 |
| CN115869312B (zh) * | 2022-12-27 | 2024-02-27 | 哈尔滨吉象隆生物技术有限公司 | 一种pdc抗肿瘤药物及其制备方法与应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6465427B1 (en) * | 1996-07-12 | 2002-10-15 | Mcgill University | Compounds and methods for modulating cell adhesion |
| ATE456655T1 (de) * | 2000-10-16 | 2010-02-15 | Genentech Inc | Behandlungsverfahren unter verwendung von wisp- polypeptiden |
| US20020193295A1 (en) * | 2001-05-04 | 2002-12-19 | Emanuel Calenoff | Immunogenic peptides and uses thereof |
| US7671010B2 (en) * | 2002-08-30 | 2010-03-02 | The Board Of Regents Of The University Of Texas System | Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
| WO2004074432A2 (en) * | 2003-01-31 | 2004-09-02 | Celldex Therapeutics, Inc. | Antibody vaccine conjugates and uses therefor |
| EP1812030A4 (en) * | 2004-10-14 | 2009-01-14 | Sopherion Therapeutics Inc | ANTI-ANGIOGENIC PEPTIDES AND METHODS OF USE THEREOF |
| US20070299043A1 (en) * | 2005-10-03 | 2007-12-27 | Hunter William L | Anti-scarring drug combinations and use thereof |
| EP2250278B1 (en) * | 2008-02-21 | 2023-04-05 | Burnham Institute for Medical Research | Methods and compositions related to peptides and proteins with c-terminal elements |
| WO2010075540A1 (en) * | 2008-12-23 | 2010-07-01 | Burnham Institute For Medical Research | Methods and compositions for synaphically-targeted treatment for cancer |
-
2009
- 2009-01-16 CN CN200980102487.1A patent/CN101951938B/zh active Active
- 2009-01-16 EP EP09730977.7A patent/EP2242764B1/en active Active
- 2009-01-16 US US12/355,672 patent/US8367621B2/en active Active
- 2009-01-16 WO PCT/US2009/031305 patent/WO2009126349A2/en not_active Ceased
- 2009-01-16 BR BRPI0906739-6A patent/BRPI0906739A2/pt not_active IP Right Cessation
- 2009-01-16 JP JP2010543285A patent/JP5985152B2/ja active Active
- 2009-01-16 CA CA 2710554 patent/CA2710554A1/en not_active Abandoned
- 2009-01-16 AU AU2009234338A patent/AU2009234338B2/en active Active
-
2013
- 2013-01-30 US US13/754,105 patent/US9115170B2/en active Active
- 2013-11-08 JP JP2013231861A patent/JP2014028862A/ja active Pending
-
2016
- 2016-03-17 JP JP2016053595A patent/JP2016121182A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011510019A5 (enExample) | ||
| ES2811065T3 (es) | Variantes de clorotoxina, conjugados y métodos para su utilización | |
| Khoshnejad et al. | Ferritin-based drug delivery systems: Hybrid nanocarriers for vascular immunotargeting | |
| US10961317B2 (en) | CD20 scFv-ELPs methods and therapeutics | |
| Kopeček et al. | Smart self‐assembled hybrid hydrogel biomaterials | |
| Snyder et al. | Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids invivo | |
| Fonseca et al. | Recent advances in the use of cell-penetrating peptides for medical and biological applications | |
| ES2548332T3 (es) | FKBP-L y usos del mismo como inhibidor de la angiogénesis | |
| JP2013518905A5 (enExample) | ||
| JP2010524968A5 (enExample) | ||
| US9110059B2 (en) | Bio-pin | |
| JP2009533317A5 (enExample) | ||
| AU2021217787A1 (en) | Treatment of PANX1 associates diseases | |
| WO2014059384A2 (en) | ICAM-1 TARGETING ELPs | |
| KR102386478B1 (ko) | 신규한 세포 투과성 펩타이드 및 이의 용도 | |
| KR102386477B1 (ko) | 신규한 세포 투과성 펩타이드 및 이의 용도 | |
| CA2857287A1 (en) | Peptide-mediated delivery of active agents across the blood-brain barrier | |
| CN111378049A (zh) | 抗肿瘤靶向融合蛋白、其偶联物及用途 | |
| CN109568289A (zh) | 胎盘样硫酸软骨素a靶向传输系统及其制备方法和应用 | |
| US10632179B2 (en) | Methods and compositions for treating cancer | |
| CN104119444B (zh) | 抗肿瘤融合蛋白及其制备方法和用途 | |
| US20220143130A1 (en) | Peptides Having Immunomodulatory Properties | |
| US11459364B2 (en) | Calbindin and BH3 domain chimeric proteins and methods for use | |
| JP6789961B2 (ja) | インテグリン標的タンパク質およびその使用方法 | |
| WO2024240103A1 (zh) | 一种类弹性蛋白多肽及其制备方法和应用 |